NORTH AMERICA AND EUROPE AGE-RELATED MACULAR DEGENERATION THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Detailed Segmentation:

• North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type (Revenue, USD Bn, 2021 - 2033)

  • Dry AMD
  • Wet AMD

• North America & Europe Age-related Macular Degeneration Therapeutics Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)

  • Aflibercept (Eylea)
  • Ranibizumab (Lucentis)
  • Bevacizumab (Avastin)
  • Pegaptanib (Macugen)
  • Verteporfin (Visudyne)
  • Brolucizumab (Beovu)
  • Supplements
  • Others

• North America & Europe Age-related Macular Degeneration Therapeutics Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

• North America & Europe Age-related Macular Degeneration Therapeutics Market, By Region (Revenue, USD Bn, 2021 - 2033)

  • North America
    • By Disease Type:
      • Dry AMD
      • Wet AMD
    • By Drug Type
      • Aflibercept (Eylea)
      • Ranibizumab (Lucentis)
      • Bevacizumab (Avastin)
      • Pegaptanib (Macugen)
      • Verteporfin (Visudyne)
      • Brolucizumab (Beovu)
      • Supplements
      • Others  
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Country:
      • U.S.
      • Canada
  • Europe
    • By Disease Type:
      • Dry AMD
      • Wet AMD
    • By Drug Type
      • Aflibercept (Eylea)
      • Ranibizumab (Lucentis)
      • Bevacizumab (Avastin)
      • Pegaptanib (Macugen)
      • Verteporfin (Visudyne)
      • Brolucizumab (Beovu)
      • Supplements
      • Others  
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe